Mitogen-activated protein kinase-activated protein kinase 2-deficient mice show increased susceptibility to Listeria monocytogenes infection

Journal of Immunology

Volumn 168, Issue 9, 2002, Pages 4667-4673

  Lehner, Martin D ^a   Schwoebel, Frank ^a   Kotlyarov, Alexey ^a   Leist, Marcel ^a   Gaestel, Matthias ^a   Hartung, Thomas ^a  

^a SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MITOGEN ACTIVATED PROTEIN KINASE 1; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FEMALE; INFECTION RESISTANCE; INFECTION SENSITIVITY; LISTERIA MONOCYTOGENES; LISTERIOSIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0036569435     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.9.4667     Document Type: Article

References (57)

1. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins
2. Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27
3. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells
4. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
5. The role of p38 activated kinase in IL-1β trancription
6. Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function
7. Pharmacological effects of S 220025, a selective inhibitior of p38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models
8. SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung
9. Role of p38 mitogen activated protein kinase in a murine model of pulmonary inflammation
10. Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB
11. PRAK, a novel protein kinase regulated by the p38 MAP kinase
12. Mitogen activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2
13. MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates
14. 3pK, a new mitogen-activated protein kinase-activated protein kinase located in the small cell lung cancer tumor suppressor gene region
15. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation
16. Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP kinase
17. p38 mitogen-activated protein kinase inhibition increases cytokine release by macrophages in vitro and during infection in vivo
18. MAPKAP kinase-2: A novel protein kinase activated by mitogen-activated protein kinase
19. MAPKAP kinase 2 is essential for LPS-induced TNF-α biosynthesis
20. Mice lacking the tumor necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes
21. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection
22. Impaired macrophage listericidal and cytokine activities are responsible for the rapid death of Listeria monocytogenes-infected IFN-γ receptor-deficient mice
23. Anti-interleukin-12 therapy protects mice in lethal endotoxemia but impairs bacterial clearance in murine Escherichia coli peritoneal sepsis
24. Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection
25. The involvement of tumor necrosis factor in immunity to Salmonella infection
26. Experimental disseminated candidiasis. II. Administration of glucocorticosteroids, susceptibility to infection, and immunity
27. Effect of hydrocortisone on macrophage response to lymphokine
28. Steroids, aspirin, and inflammation
29. Comparative effects of corticosteroids on host resistance to infection in relation to chemical structure
30. Structure-function-relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus
31. A rapid microplate-based fluorometric assay for phagocytosis
32. 15N]nitrate in biological fluids
33. Analysis and assessment of the capacity of neutrophils to produce reactive oxygen species in a 96-well microplate format using lucigenin- and luminol-dependent chemiluminescence
34. Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: Correlation with inefficient neutrophilia
35. Effects of interleukin-1 receptor antagonist overexpression on infection by Listeria monocytogenes
36. Cytokines and the host defense against Listeria monocytogenes and Salmonella typhimurium
37. Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase
38. Mechanism of the intracellular killing and modulation of antibiotic susceptibility of Listeria monocytogenes in THP-1 macrophages activated by γ interferon
39. Reduced antilisterial activity of TNF-deficient bone marrow-derived macrophages is due to impaired superoxide production
40. Release of nitric oxide during the T cell-independent pathway of macrophage activation: Its role in resistance to Listeria monocytogenes
41. Nitric oxide produced during murine listeriosis is protective
42. Synergistic cooperation between T cell lymphokines for induction of the nitric oxide synthase gene in murine peritoneal macrophages
43. Tumor necrosis factor-α synergizes with IFN-γ in mediating killing of Leishmania major through the induction of nitric oxide
44. -/- mice: Protection despite absence of ROI and susceptibility despite presence of RNI
45. Crucial role of interferon consensus sequence binding protein, but neither of interferon regulatory factor 1 nor of nitric oxide synthesis for protection against murine listeriosis
46. TNF-α and IFN-γ stimulate a macrophage precursor cell line to kill Listeria monocytogenes in a nitric oxide-independent manner
47. Listeria monocytogenes modulates macrophage cytokine responses through STAT serinephosphorylation and the induction of suppressor of cytokine signaling 3
48. Involvement of MAP-kinases and -phosphatases in uptake and intracellular replication of Listeria monocytogenes in J774 macrophage cells
49. Listeria monocytogenes invasion of epithelial cells requires the MEK-1/ERK-2 mitogen-activated protein kinase pathway
50. Critical roles of neutrophils in host defense against experimental systemic infections of mice by Listeria monocytogenes, Salmonella typhimurium, and Yersinia enterocolitica
51. Effector function of hepatocytes and Kupffer cells in the resolution of systemic bacterial infections
52. Characterization of the pattern of inflammatory cell influx and cytokine production during the murine host response to Listeria monocytogenes
53. Primary and secondary immune response to Listeria monocytogenes
54. Human Toll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or lipopolysaccharide
55. Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different Toll-like receptors independent of paracrine mediators
56. Toll-like receptor 4, but not Toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides
57. Activation of MAP kinase-activated protein kinase 2 in human neutrophils after phorbol ester or fMLP peptide stimulation